logo
RENAL FAILURE
STANDARDIZATION OF THE MEASUREMENTS OF CREATININE AND NEW MARKERS OF RENAL INSUFFICIENCY: AN UPDATE
GLOMERULAR FILTRATION RATE MEASUREMENT: FROM EQUATIONS TO REPORT CONSENSUS
URINARY ALBUMIN EXCRETION IN CHRONIC KIDNEY DISEASE: CRITICAL ISSUES IN MEASUREMENT AND REPORTING
TAMOXIFEN: THE FIRST TARGETED-THERAPY TO MANAGE PATIENTS AFFECTED BY EARLY BREAST CANCER: IS THERE STILL A ROLE FOR IT?
THE SHIFT FROM BIOCHEMICAL TO IMMUNOHISTOCHEMICAL METHODS FOR THE DETERMINATION OF OESTROGEN RECEPTORS IN BREAST CANCER: AN EVIDENCE BASED DECISIONAL PROCESS?
MOLECULAR APPROACH FOR SELECTION OF ENDOCRINE-BASED THERAPY IN BREAST CANCER TREATMENT
THE SIMULTANEOUS ASSESSMENT OF CIRCULATING LEVELS OF FREE CA15.3 AND CA15.3-IGM FOR IMPROVING BREAST CANCER DETECTION
DIAGNOSTIC-THERAPEUTIC “COMPARED”
THE “WEIGHT” OF EVIDENCE BASED MEDICINE
PRE-ANALYTICAL AND ANALYTICAL PHASE
BIOLOGICAL VARIABILITY OF GLYCATED HEMOGLOBIN: A SYSTEMATIC REVIEW OF THE LITERATURE
SCREENING AND DIAGNOSIS OF GDM: A NEW APPROACH
BIOMARKERS: STATE OF THE ART AND PROSPECTIVES
CAN WE PERSONALIZE DRUG THERAPY IN COLORECTAL CANCER PATIENTS?
HIGH SENSITIVITY C-REACTIVE PROTEIN AND OTHER MARKERS OF CARDIOVASCULAR INFLAMMATION: FROM BANCH TO PROVE OF EFFICACY
NON INVASIVE DIAGNOSIS OF GASTROINTESTINAL DISORDERS: GASTROPANEL AND FIBROTEST
CLINICAL RISK: IS IT A PROBLEM OR AN OPPORTUNITY?
FMEA-FMECA: A RISK MANAGEMENT’S STRUMENT CRITICAL PROCESSES
PRE-ANALYTICAL PHASE: RISK MANAGEMENT AND RISK ASSESSMENT PRODUCTIONS OF A HOSPITAL LABORATORY
RISK MANAGEMENT TRIGGERS IN POSTANALYTICAL PHASE
MODEL OF QUALITY INDICATORS: A PROJECT OF THE ’IFCC-WG “LABORATORY ERRORS AND PATIENT SAFETY”
ANALYTICAL QUALITY CONTROL
THE USE OF PORTABLE GLUCOSE METERS
HOW TO BUILD A QUALITY PROCESS
ARE THE LABORATORY PLASMA LIPID REPORTS OF HELP FOR THE DIABETIC PATIENT MANAGEMENT? RESULTS FROM A SURVEY AMONG ITALIAN LABORATORIES
CHILDREN’S OBESITY ATHEROSCLEROTICS RISK: THE ROLE OF INFLAMMATORY MARKERS (hs-CRP), OXIDANT STATUS (PGF-2alfa,MDA), ANTI-OXIDANT STATUS (VITAMIN E) AND INSULIN SENSITIVITY
THE STATE OF THE ART OF WORKPLACE DRUG TESTING IN EUROPE
PROCEDURES FOR WORKPLACE DRUG TESTING IN ITALY
WORKPLACE ALCOHOL ABUSE TESTING: COMPARISON OF ETHYL GLUCURONIDE IN HAIR AND CDT IN
VKORC1 AND CYP2C9 PHARMACOGENETICS: RELEVANCE IN WARFARIN MAINTENANCE DOSING PREDICTION
CYP2D6 GENOTYPING PANEL ANALYZED ON THE INFINITI TM ANALYZER WORKSTATION
PHARMACOGENETICS: PROMISES OR REALITY?
PHARMACOGENETICS AND DIABETES
PHARMACOGENETICS OF ORAL ANTICOAGULANT THERAPY
NEONATAL SCREENING OF INBORN ERRORS OF METABOLISM
NEWBORN SCREENING FOR GENETIC DISORDERS: LIGHT AND SHADOW. EXPERT OPINION
HPV SCREENING
THE FUNCTION OF GYNAECOLOGIST IN THE SCREENING OF HPV
THE COLORECTAL CANCER SCREENING
BIOCHEMICAL SCREENING FOR TRAINING EVALUATION IN PROFESSIONAL SOCCER PLAYERS
THIRTY-FIVE YEARS OF THALASSEMIA SCREENING IN LATIUM REGION: ACTIVITIES, RESULTS AND PERSPECTIVES
MONOCLONAL B LYMPHOCYTOSIS; DIAGNOSIS AND NATURAL S.M.Y.
BIOLOGICAL PROGNOSTIC MARKERS IN B-CELL CHRONIC LYMPHOCYTIC LEUKEMIA
DATA MINING IN FLOW CYTOMETRY DATA ANALYSIS
A NEW METHOD FOR THE SCREENING OF CHRONIC LYMPHATIC LEUKEMIA
PAROXYMAL NOCTURNAL HEMOGLOBINURIA: TWO CASES REPORT
Cardiac troponins: what we knew, what we know - where are we now?
Measurement of circulating concentrations of cardiac troponin I and T in healthy subjects: a tool for monitoring myocardial tissue renewal?
A critical appraisal of experimental factors influencing the definition of the 99th percentile limit for cardiac troponins
Genetic and biochemical heterogeneity of cardiac troponins: clinical and laboratory implications
The future of hospital laboratories. Position statement from the Royal Belgian Society of Clinical Chemistry (RBSCC)1)
Quantity quotient reporting. A proposal for a standardized presentation of laboratory results
Quantity quotient reporting. Counterpoint
Increasing laboratory medicine activities in China: research and publications
Contributions in Biochemistry and Molecular Biology from China and other top-ranking countries: a 10-year survey of the literature
SOCS3 and IRS-1 gene expression differs between genotype 1 and genotype 2 hepatitis C virus-infected HepG2 cells
Polymorphisms of the β1-adrenergic receptor gene are associated with essential hypertension in Chinese
Egyptian glycogen storage disease type III - identification of six novel AGL mutations, including a large 1.5 kb deletion and a missense mutation p.L620P with subtype IIId
Novel rare alleles of ABCA1 are exclusively associated with extreme high-density lipoprotein-cholesterol levels among the Han Chinese
-308G>A and -1031T>C tumor necrosis factor gene polymorphisms in Tunisian patients with coronary artery disease
Error tracking in a clinical biochemistry laboratory
HbA1c measurements from dried blood spots: validation and patient satisfaction
Pre-transplant serum concentrations of anti-endothelial cell antibody in panel reactive antibody negative renal recipients and its impact on acute rejection
Detection of Meningeosis neoplastica by real-time quantitation of telomerase activity
The prognostic utility of haptoglobin genotypes in squamous cell carcinoma of the head and neck
Evaluation of a new method for the diagnosis of alterations of Lens culinaris agglutinin binding of thyroglobulin molecules in thyroid carcinoma
The soluble transferrin receptor (TfR)-F-Index is not applicable as a test for iron status in patients with chronic lymphocytic leukemia
Impact of calibration fitting models on the clinical value of chromogranin A
Clinical value of a competitive NT-proBNP enzyme immunoassay compared to the Roche NT-proBNP platform
Should gender-related reference values be used for total bilirubin?
A novel nonsense mutation in the albumin gene (c.1275 C>A) causing analbuminemia in a Tunisian boy